• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阻断离子通道KCNN4可减轻小鼠实验性自身免疫性脑脊髓炎的症状。

Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice.

作者信息

Reich Eva-Pia, Cui Long, Yang Lily, Pugliese-Sivo Catherine, Golovko Andrei, Petro Mary, Vassileva Galya, Chu Inhou, Nomeir Amin A, Zhang Li-Kang, Liang Xian, Kozlowski Joseph A, Narula Satwant K, Zavodny Paul J, Chou Chuan-Chu

机构信息

Schering-Plough Research Institute, Kenilworth, New Jersey 07033, USA.

出版信息

Eur J Immunol. 2005 Apr;35(4):1027-36. doi: 10.1002/eji.200425954.

DOI:10.1002/eji.200425954
PMID:15770697
Abstract

The KCNN4 potassium-ion channel has been reported to play an important role in regulating antigen-induced T cell effector functions in vitro. This study presents the first evidence that a selective KCNN4 blocker, TRAM-34, confers protection against experimental autoimmune encephalomyelitis (EAE) in the mouse model. Treatment with the KCNN4 blocker did not prevent infiltration of T cells in the spinal cord, but resulted in the reduction of both the protein and the message levels of TNF-alpha and IFN-gamma as well as the message levels of several other pro-inflammatory molecules in the spinal cord. Plasma concentrations of TRAM-34 within a 24-h period were between the in vitro IC(50) and IC(90) values for the KCNN4 channel. The effect of TRAM-34 was reversible, as indicated by the development of clinical EAE symptoms within 48 h after withdrawal of treatment. In summary, our data support the idea that KCNN4 channels play a critical role in the immune response during the development of MOG-induced EAE in C57BL/6 mice.

摘要

据报道,KCNN4钾离子通道在体外调节抗原诱导的T细胞效应功能中发挥重要作用。本研究首次证明,选择性KCNN4阻滞剂TRAM-34在小鼠模型中对实验性自身免疫性脑脊髓炎(EAE)具有保护作用。用KCNN4阻滞剂治疗并未阻止T细胞浸润脊髓,但导致脊髓中TNF-α和IFN-γ的蛋白质和信使水平以及其他几种促炎分子的信使水平降低。TRAM-34在24小时内的血浆浓度介于KCNN4通道的体外IC(50)和IC(90)值之间。TRAM-34的作用是可逆的,停药后48小时内出现临床EAE症状即表明了这一点。总之,我们的数据支持这样的观点,即KCNN4通道在C57BL/6小鼠MOG诱导的EAE发展过程中的免疫反应中起关键作用。

相似文献

1
Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice.阻断离子通道KCNN4可减轻小鼠实验性自身免疫性脑脊髓炎的症状。
Eur J Immunol. 2005 Apr;35(4):1027-36. doi: 10.1002/eji.200425954.
2
Blockade of Ca2+-activated K+ channels in T cells: an option for the treatment of multiple sclerosis?阻断T细胞中钙激活钾通道:治疗多发性硬化症的一种选择?
Eur J Immunol. 2005 Apr;35(4):1023-6. doi: 10.1002/eji.200526078.
3
Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis.用抗粒细胞抗体治疗可抑制实验性自身免疫性脑脊髓炎的效应阶段。
J Immunol. 1998 Dec 1;161(11):6421-6.
4
Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.口服1,4-芳基-2-巯基咪唑可抑制小鼠实验性自身免疫性脑脊髓炎模型中的T细胞增殖并降低临床严重程度。
J Pharmacol Exp Ther. 2009 Dec;331(3):1005-13. doi: 10.1124/jpet.109.154948. Epub 2009 Sep 9.
5
Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis.抗TWEAK单克隆抗体可减少中枢神经系统中的免疫细胞浸润以及实验性自身免疫性脑脊髓炎的严重程度。
Clin Immunol. 2005 Oct;117(1):15-23. doi: 10.1016/j.clim.2005.06.005.
6
MPTP-induced central dopamine depletion exacerbates experimental autoimmune encephalomyelitis (EAE) in C57BL mice.1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)诱导的中枢多巴胺耗竭会加重C57BL小鼠的实验性自身免疫性脑脊髓炎(EAE)。
Inflamm Res. 2007 Aug;56(8):311-7. doi: 10.1007/s00011-007-6128-0.
7
Elevated interferon gamma expression in the central nervous system of tumour necrosis factor receptor 1-deficient mice with experimental autoimmune encephalomyelitis.肿瘤坏死因子受体1缺陷型实验性自身免疫性脑脊髓炎小鼠中枢神经系统中干扰素γ表达升高。
Immunology. 2006 Aug;118(4):527-38. doi: 10.1111/j.1365-2567.2006.02395.x. Epub 2006 Jun 16.
8
KCa3.1: target and marker for cancer, autoimmune disorder and vascular inflammation?KCa3.1:癌症、自身免疫性疾病和血管炎症的靶点及标志物?
Expert Rev Mol Diagn. 2008 Mar;8(2):179-87. doi: 10.1586/14737159.8.2.179.
9
Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine.停用苯妥英钠和卡马西平后实验性自身免疫性脑脊髓炎病情加重。
Ann Neurol. 2007 Jul;62(1):21-33. doi: 10.1002/ana.21172.
10
CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.CCR6通过控制调节性CD4 + T细胞募集到靶组织来调节实验性自身免疫性脑脊髓炎(EAE)的发病机制。
Eur J Immunol. 2009 Jun;39(6):1671-81. doi: 10.1002/eji.200839123.

引用本文的文献

1
Cyclosporine A Accelerates Neurorecovery Transcriptional Trajectory in a Swine Model of Diffuse Traumatic Brain Injury.环孢素A在弥漫性创伤性脑损伤猪模型中加速神经恢复转录轨迹。
Int J Mol Sci. 2025 Apr 9;26(8):3531. doi: 10.3390/ijms26083531.
2
Challenges in the Therapeutic Targeting of KCa Channels: From Basic Physiology to Clinical Applications.钾通道治疗靶点面临的挑战:从基础生理学到临床应用
Int J Mol Sci. 2024 Mar 4;25(5):2965. doi: 10.3390/ijms25052965.
3
Staphylococcus aureus α-toxin impairs early neutrophil localization via electrogenic disruption of store-operated calcium entry.
金黄色葡萄球菌α-毒素通过电致破坏储存操作钙内流来损害早期中性粒细胞定位。
Cell Rep. 2023 Nov 28;42(11):113394. doi: 10.1016/j.celrep.2023.113394. Epub 2023 Nov 10.
4
Neuroprotection in an Experimental Model of Multiple Sclerosis via Opening of Big Conductance, Calcium-Activated Potassium Channels.通过开放大电导钙激活钾通道对多发性硬化症实验模型进行神经保护
Pharmaceuticals (Basel). 2023 Jul 7;16(7):972. doi: 10.3390/ph16070972.
5
Repurposing the K3.1 Blocker Senicapoc for Ischemic Stroke.再利用 K3.1 阻断剂 Senicapoc 治疗缺血性脑卒中。
Transl Stroke Res. 2024 Jun;15(3):518-532. doi: 10.1007/s12975-023-01152-6. Epub 2023 Apr 24.
6
morphological alterations of TAMs during KCa3.1 inhibition-by using two-photon time-lapse technology.在抑制KCa3.1期间TAM的形态学改变——采用双光子延时技术
Front Cell Neurosci. 2022 Dec 15;16:1002487. doi: 10.3389/fncel.2022.1002487. eCollection 2022.
7
Effect of the KCa3.1 blocker, senicapoc, on cerebral edema and cardiovascular function after cardiac arrest - A randomized experimental rat study.钾通道蛋白3.1(KCa3.1)阻滞剂司尼可泊对心脏骤停后脑水肿和心血管功能的影响——一项随机实验性大鼠研究。
Resusc Plus. 2021 Apr 2;6:100111. doi: 10.1016/j.resplu.2021.100111. eCollection 2021 Jun.
8
The potassium channel KCa3.1 represents a valid pharmacological target for microgliosis-induced neuronal impairment in a mouse model of Parkinson's disease.钾通道 KCa3.1 是帕金森病小鼠模型中小胶质细胞激活诱导神经元损伤的有效药物靶点。
J Neuroinflammation. 2019 Dec 26;16(1):273. doi: 10.1186/s12974-019-1682-2.
9
Ion channels as therapeutic antibody targets.离子通道作为治疗性抗体的靶标。
MAbs. 2019 Feb/Mar;11(2):265-296. doi: 10.1080/19420862.2018.1548232. Epub 2018 Dec 10.
10
Physiological Roles and Therapeutic Potential of Ca Activated Potassium Channels in the Nervous System.钙激活钾通道在神经系统中的生理作用及治疗潜力
Front Mol Neurosci. 2018 Jul 30;11:258. doi: 10.3389/fnmol.2018.00258. eCollection 2018.